XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Mar. 30, 2024
Apr. 01, 2023
Net sales $ 1,834,595 $ 2,320,103 $ 3,709,393 $ 4,675,911
Cost of sales 1,679,838 2,128,914 3,393,796 4,289,336
Gross profit 154,757 191,189 315,597 386,575
Operating expenses:        
Selling, general and administrative 69,199 63,390 133,984 124,120
Research and development 6,323 6,394 12,612 11,993
Restructuring 3,274 804 5,464 1,435
Total operating expenses 78,796 70,588 152,060 137,548
Operating income 75,961 120,601 163,537 249,027
Interest income 3,412 2,539 7,069 5,472
Interest expense (8,218) (9,286) (16,630) (17,967)
Other income (expense) 3,276 (2,768) 2,143 (9,480)
Interest and other, net (1,530) (9,515) (7,418) (21,975)
Income before income taxes 74,431 111,086 156,119 227,052
Provision for income taxes 19,122 25,779 40,446 46,631
Net income before noncontrolling interest 55,309 85,307 115,673 180,421
Less: Net income attributable to noncontrolling interest 2,824 5,686 6,120 8,786
Net income attributable to common shareholders $ 52,485 $ 79,621 $ 109,553 $ 171,635
Net income attributable to common shareholders per share:        
Basic $ 0.94 $ 1.37 $ 1.95 $ 2.96
Diluted $ 0.93 $ 1.33 $ 1.91 $ 2.87
Weighted-average shares used in computing per share amounts:        
Basic 55,585 58,269 56,062 57,999
Diluted 56,699 59,819 57,470 59,863